187 related articles for article (PubMed ID: 29441505)
1. Eliciting the Monetary Value of a Quality-Adjusted Life Year in a Greek Outpatient Department in Times of Economic Austerity.
Mavrodi A; Aletras V; Spanou A; Niakas D
Pharmacoecon Open; 2017 Dec; 1(4):291-300. PubMed ID: 29441505
[TBL] [Abstract][Full Text] [Related]
2. A Contingent Valuation Study for Eliciting a Monetary Value of a Quality-Adjusted Life-Year in the General Greek Population.
Mavrodi A; Aletras V
Value Health Reg Issues; 2020 Sep; 22():36-43. PubMed ID: 32731168
[TBL] [Abstract][Full Text] [Related]
3. Willingness to pay for a quality-adjusted life-year: the individual perspective.
Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
[TBL] [Abstract][Full Text] [Related]
4. Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand.
Nimdet K; Ngorsuraches S
BMJ Open; 2015 Oct; 5(10):e008123. PubMed ID: 26438135
[TBL] [Abstract][Full Text] [Related]
5. Estimation of the value of curative therapies in oncology: a willingness-to-pay study in China.
Huang L; Peng X; Sun L; Zhang D
Cost Eff Resour Alloc; 2023 Jun; 21(1):37. PubMed ID: 37277820
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?
Nimdet K; Chaiyakunapruk N; Vichansavakul K; Ngorsuraches S
PLoS One; 2015; 10(4):e0122760. PubMed ID: 25855971
[TBL] [Abstract][Full Text] [Related]
7. Estimating a WTP-based value of a QALY: the 'chained' approach.
Robinson A; Gyrd-Hansen D; Bacon P; Baker R; Pennington M; Donaldson C;
Soc Sci Med; 2013 Sep; 92():92-104. PubMed ID: 23849283
[TBL] [Abstract][Full Text] [Related]
8. An exploratory study to estimate cost-effectiveness threshold value for life saving treatments in western Iran.
Moradi N; Woldemichael A; Malekian P; Rotvandi DM; Rezaei S
Cost Eff Resour Alloc; 2020; 18():47. PubMed ID: 33110399
[TBL] [Abstract][Full Text] [Related]
9. Monetary Value of Quality-Adjusted Life Years (QALY) among Patients with Cardiovascular Disease: a Willingness to Pay Study (WTP).
Moradi N; Rashidian A; Rasekh HR; Olyaeemanesh A; Foroughi M; Mohammadi T
Iran J Pharm Res; 2017; 16(2):823-833. PubMed ID: 28979338
[TBL] [Abstract][Full Text] [Related]
10. Empirical Monetary Valuation of a Quality-Adjusted Life-Year in the Kingdom of Saudi Arabia: A Willingness-to-Pay Analysis.
Bazarbashi S; De Vol EB; Maraiki F; Al-Jedai A; Ali AA; Alhammad AM; Aljuffali IA; Iskedjian M
Pharmacoecon Open; 2020 Dec; 4(4):625-633. PubMed ID: 32291726
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of willingness to pay per quality-adjusted life year for a cure: A contingent valuation method using a scenario-based survey.
Song HJ; Lee EK
Medicine (Baltimore); 2018 Sep; 97(38):e12453. PubMed ID: 30235732
[TBL] [Abstract][Full Text] [Related]
12. Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences.
Martín-Fernández J; Polentinos-Castro E; del Cura-González MI; Ariza-Cardiel G; Abraira V; Gil-LaCruz AI; García-Pérez S
BMC Health Serv Res; 2014 Jul; 14():287. PubMed ID: 24989615
[TBL] [Abstract][Full Text] [Related]
13. Willingness to pay for a QALY: theoretical and methodological issues.
Gyrd-Hansen D
Pharmacoeconomics; 2005; 23(5):423-32. PubMed ID: 15896094
[TBL] [Abstract][Full Text] [Related]
14. Comparing the monetary value of a quality-adjusted life year from the payment card and the open-ended format.
Ye Z; Liu F; Ma J; Zhou Z; Wang C; Sun L
Cost Eff Resour Alloc; 2021 Jul; 19(1):45. PubMed ID: 34281574
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of process utility: elucidating preferences for a non-invasive procedure to treat restenosis.
Aviles-Blanco MV
Health Econ Rev; 2021 Jul; 11(1):27. PubMed ID: 34297212
[TBL] [Abstract][Full Text] [Related]
16. WTP for a QALY and health states: More money for severer health states?
Shiroiwa T; Igarashi A; Fukuda T; Ikeda S
Cost Eff Resour Alloc; 2013; 11():22. PubMed ID: 24128004
[TBL] [Abstract][Full Text] [Related]
17. Willingness to Pay for One Additional Quality Adjusted Life Year: A Population Based Survey from China.
Ye Z; Abduhilil R; Huang J; Sun L
Appl Health Econ Health Policy; 2022 Nov; 20(6):893-904. PubMed ID: 35934772
[TBL] [Abstract][Full Text] [Related]
18. Willingness to pay for one quality-adjusted life year in Iran.
Moradi N; Rashidian A; Nosratnejad S; Olyaeemanesh A; Zanganeh M; Zarei L
Cost Eff Resour Alloc; 2019; 17():4. PubMed ID: 30867654
[TBL] [Abstract][Full Text] [Related]
19. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
20. The Willingness to Pay for a Quality Adjusted Life Year: A Review of the Empirical Literature.
Ryen L; Svensson M
Health Econ; 2015 Oct; 24(10):1289-1301. PubMed ID: 25070495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
